Post on 20-Jun-2015
transcript
1
3
4
5
6
7
is No.2 in the Japanese market
and it has a solid reputation as a leader
in research based medicine; has invested
around 1.345 (bn$) in research &
development in 2008 with a total
commitment to further investment,
& has research & development units at
over 15 locations all around the world
including North America, Europe & Asia.
is the No. 3 in the Japanese market
& has invested 1.64 (bn$) in research &
development in 2008 and will continue
to invest with a number of major
products in the research & development
pipeline, which is well positioned to
meet the healthcare needs of the future.
8
9
10
11
12
13
14
15
16
17
18
19
20
http://www.sajaonline.netSAJA Pharmaceuticals Co. Ltd. ,
P. O. Box 42600 Jeddah 21551 Kingdom of Saudi Arabia.
Jeddah Head Office; Tel: +966 2 6435600 Fax: +966 2 6444173
Factory; Tel: +966 2 6080514 Fax:+966 2 6379997
GCC Scientific office, P.O.Box 23181 Sharjah .UAE
Tel. : +971 6 555 44 68 Fax.: +971 6 55 9 22 86
North Africa Scientific office,Egypt, Cairo , Al Nozha Al Gadeeda
24 Dr. Ahmed Mostafa Street Multipharma Scientific OfficeTel.: +202 262 162 91 Fax: +202 26216281